keyword
MENU ▼
Read by QxMD icon Read
search

in-vivo dosimetry

keyword
https://www.readbyqxmd.com/read/29025984/synthesis-and-biological-evaluation-of-a-novel-18-f-labeled-adnectin-as-a-pet-radioligand-for-imaging-pd-l1-expression
#1
David J Donnelly, Ralph Adam Smith, Paul Morin, Dasa Lipovsek, Jochem Gokemeijer, Daniel Cohen, Virginie Lafont, Tritin Tran, Erin Lee Cole, Martin Wright, Joonyoung Kim, Adrienne Pena, Daniel Kukral, Douglas D Dischino, Patrick Chow, Jinping Gan, Olufemi Adelakun, Xi-Tao Wang, Kai Cao, David Lueng, Samuel Bonacorsi, Wendy Hayes
The programmed death protein (PD-1) and its ligand (PD-L1) play critical roles in a checkpoint pathway cancer cells exploit to evade the immune system. A same-day PET imaging agent for measuring PD-L1 status in primary and metastatic lesions could be important for optimizing drug therapy. Herein, we have evaluated the tumor targeting of an anti-PD-L1 Adnectin after (18)F-fluorine labeling. Methods: An anti-PD-L1 Adnectin was labeled with (18)F in two steps. This synthesis featured fluorination of a novel prosthetic group, followed by a copper-free click conjugation to a modified Adnectin to generate (18)F-BMS-986192...
October 12, 2017: Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine
https://www.readbyqxmd.com/read/29017719/comparison-of-gamma-and-dvh-based-in-vivo-dosimetric-plan-evaluation-for-pelvic-vmat-treatments
#2
Erik van der Bijl, René F M van Oers, Igor Olaciregui-Ruiz, Anton Mans
BACKGROUND AND PURPOSE: To compare DVH-based quality assurance to a multi-parametric γ-based methodology for in vivo EPID dosimetry for VMAT to the pelvis. MATERIALS AND METHODS: For 47 rectum, 37 prostate, and 44 bladder VMAT treatments we reconstructed the 3D dose distributions of 387 fractions from in vivo EPID dosimetry. The difference between planned and measured dose was evaluated using γ analysis (3%/3mm) in the 50% isodose volume (IDV) and DVH differences (ΔD2, ΔD50 and ΔD98) of targets and organs at risk...
October 7, 2017: Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology
https://www.readbyqxmd.com/read/28994669/minibeam-radiotherapy-with-small-animal-irradiators-i-in-vitro-i-and-i-in-vivo-i-feasibility-studies
#3
Soha Bazyar, Christina R Inscoe, E Timothy O'Brien Iii, Otto Z Zhou, Yueh Z Lee
Minibeam radiation therapy (MBRT) delivers ultrahigh dose of X-ray (≥100 Gy) in 200-1000 μm beams (peaks), separated by wider non-irradiated regions (valleys) usually as a single temporal fraction. Preclinical studies performed at synchrotron facilities revealed that MBRT is able to ablate tumors while maintaining normal tissue integrity. The main purpose of present study was to develop an efficient and accessible method to perform MBRT using a conventional X-ray irradiator. We then tested this new method both in-vitro and in-vivo...
October 10, 2017: Physics in Medicine and Biology
https://www.readbyqxmd.com/read/28990682/ex-vivo-feasibility-study-of-endoscopic-intraductal-laser-ablation-of-the-breast
#4
Tjeerd de Boorder, Laurien Waaijer, Paul J van Diest, Arjen J Witkamp
OBJECTIVE: To determine the feasibility and safety of breast endoscopic thulium laser ablation for treatment of intraductal neoplasia. STUDY DESIGN: Ductoscopy is a minimally invasive endoscopic approach of the milk ducts of the breast via the nipple. Besides diagnosis in women with pathologic nipple discharge (PND), it allows non-invasive removal of intraductal lesions with a stalk like papillomas. Removal, however, is often incomplete and flat lesions cannot be targeted...
October 9, 2017: Lasers in Surgery and Medicine
https://www.readbyqxmd.com/read/28985433/thyroid-phantom-measurements-in-joint-eurados-llnl-intercomparison-exercise
#5
David P Hickman, Lori Collins, Didier Franck, Ruth N Harding, Karen L Jeffers, Maria A López Ponte, Lydia I Tai
The European Radiation Dosimetry Group (EURADOS), in collaboration with Lawrence Livermore National Laboratory's (LLNL's) Thyroid Intercomparison Program (TRIP), conducted an intercomparison exercise consistent with the goals of EURADOS. In total, 35 in vivo radiobioassay facilities from 18 countries participated to evaluate the differences between the neck and thyroid phantoms specified in two standards issued by the American National Standards Institute. Radioiodine (125I and 131I) measurement results were compared to the traceable standard activity levels added to each phantom...
July 15, 2017: Radiation Protection Dosimetry
https://www.readbyqxmd.com/read/28976913/monte-carlo-simulation-of-radiation-transport-and-dose-deposition-from-locally-released-gold-nanoparticles-labeled-with-sup-111-sup-in-sup-177-sup-lu-or-sup-90-sup-y-incorporated-into-tissue-implantable-depots
#6
Priscilla Lai, Zhongli Cai, Jean-Philippe Pignol, Eli Lechtman, Shahram Mashouf, Yijie Lu, Mitchell A Winnik, David A Jaffray, Raymond M Reilly
Permanent seed implantation (PSI) brachytherapy is a highly conformal form of radiation therapy but is challenged with dose inhomogeneity due to its utilization of low energy radiation sources. Gold nanoparticles (AuNP) conjugated with electron emitting radionuclides have recently been developed as a novel form of brachytherapy and can aid in homogenizing dose through physical distribution of radiolabeled AuNP when injected intratumorally (i.t.) in suspension. However, the distribution is unpredictable and precise placement of many injections would be difficult...
October 4, 2017: Physics in Medicine and Biology
https://www.readbyqxmd.com/read/28973375/comparative-dose-response-analysis-of-liver-and-kidney-transcriptomic-effects-of-trichloroethylene-and-tetrachloroethylene-in-b6c3f1-mouse
#7
Yi-Hui Zhou, Joseph A Cichocki, Valerie Y Soldatow, Elizabeth Scholl, Paul Gallins, Dereje Jima, Hong-Sik Yoo, Weihsueh A Chiu, Fred A Wright, Ivan Rusyn
Trichloroethylene (TCE) and tetrachloroethylene (PCE) are ubiquitous environmental contaminants and occupational health hazards. Recent health assessments of these agents identified several critical data gaps, including lack of comparative analysis of their effects. This study examined liver and kidney effects of TCE and PCE in a dose-response study design. Equimolar doses of TCE (24, 80, 240, 800 mg/kg) or PCE (30, 100, 300, 1,000 mg/kg) were administered by gavage in aqueous vehicle to male B6C3F1/J mice...
August 16, 2017: Toxicological Sciences: An Official Journal of the Society of Toxicology
https://www.readbyqxmd.com/read/28971446/determination-of-soft-tissue-breakpoint-based-on-its-temperature-enhancement-pattern-in-vivo-and-in-vitro-experiments
#8
C Austerlitz, I Gkigkitzis, A L S Barros, J Melo, I Haranas, D Campos
The breakpoint of fresh commercial meats and in vivo mice has been assessed using tissue temperature enhancement pattern. A 1 cm length and 0.1 cm diameter gold rod was implanted in fresh chicken breast, beef, fish, and in vivo Mus musculus white mice and was insonated with ultrasound. The temperature enhancement of gold rods was measured with a needle type thermistor over a temperature range from 35 to 50 °C. From these results the breakpoints were determined by plotting the gold rod temperature versus ultrasound exposure duration using the interception point of two curves fitted by a linear regression equations of thermal response above and below 43 °C...
2017: Advances in Experimental Medicine and Biology
https://www.readbyqxmd.com/read/28964727/semiconductor-real-time-quality-assurance-dosimetry-in-brachytherapy
#9
REVIEW
Mauro Carrara, Dean Cutajar, Saree Alnaghy, Anthony Espinoza, Anna Romanyukha, Stefano Presilla, Chiara Tenconi, Annamaria Cerrotta, Carlo Fallai, Mitra Safavi-Naeini, Marco Petasecca, Alannah Kejda, Michael Lerch, Stéphanie Corde, Michael Jackson, Andrew Howie, Joseph Bucci, Anatoly B Rosenfeld
With the increase in complexity of brachytherapy treatments, there has been a demand for the development of sophisticated devices for delivery verification. The Centre for Medical Radiation Physics (CMRP), University of Wollongong, has demonstrated the applicability of semiconductor devices to provide cost-effective real-time quality assurance for a wide range of brachytherapy treatment modalities. Semiconductor devices have shown great promise to the future of pretreatment and in vivo quality assurance in a wide range of brachytherapy treatments, from high-dose-rate (HDR) prostate procedures to eye plaque treatments...
September 27, 2017: Brachytherapy
https://www.readbyqxmd.com/read/28963927/human-biodistribution-and-dosimetry-of-18-f-nifene-an-%C3%AE-4%C3%AE-2-nicotinic-acetylcholine-receptor-pet-tracer
#10
Tobey J Betthauser, Ansel T Hillmer, Patrick J Lao, Emily Ehlerding, Jogeshwar Mukherjee, Charles K Stone, Bradley T Christian
INTRODUCTION: The α4β2* nicotinic acetylcholine receptor (nAChR) system is implicated in many neuropsychiatric pathologies. [(18)F]Nifene is a positron emission tomography (PET) ligand that has shown promise for in vivo imaging of the α4β2* nAChR system in preclinical models and humans. This work establishes the radiation burden associated with [(18)F]nifene PET scans in humans. METHODS: Four human subjects (2M, 2F) underwent whole-body PET/CT scans to determine the human biodistribution of [(18)F]nifene...
August 17, 2017: Nuclear Medicine and Biology
https://www.readbyqxmd.com/read/28943129/time-resolved-in%C3%A2-vivo-dosimetry-for-source-tracking-in-brachytherapy
#11
Jacob Graversen Johansen, Susanne Rylander, Simon Buus, Lise Bentzen, Steffen Bjerre Hokland, Christian Skou Søndergaard, Anders Karl Mikael With, Gustavo Kertzscher, Kari Tanderup
PURPOSE: The purpose of this article is to demonstrate that brachytherapy source tracking can be realized with in vivo dosimetry. This concept could enable real-time treatment monitoring. METHODS: In vivo dosimetry was incorporated in the clinical routine during high-dose-rate prostate brachytherapy at Aarhus University Hospital. The dosimetry was performed with a radioluminescent crystal positioned in a dedicated brachytherapy needle in the prostate. The dose rate was recorded every 50-100 ms during treatment and analyzed retrospectively...
September 21, 2017: Brachytherapy
https://www.readbyqxmd.com/read/28942677/a-novel-device-for-intraoperative-photodynamic-therapy-dedicated-to-glioblastoma-treatment
#12
Clément Dupont, Serge Mordon, Pascal Deleporte, Nicolas Reyns, Maximilien Vermandel
AIM: Photodynamic therapy (PDT) appears to be a valuable new treatment modality for cancer therapy. Studies have reported successful application of PDT for glioblastoma. Here, we introduce a new device dedicated to intraoperative PDT delivered early after fluoro-guided resection combined with a transfer function that determines the treatment time based on the size of the surgical resection cavity. MATERIALS & METHODS: First, we describe the device, which is composed of a trocar, a balloon filled with a diffusing solution, and a fiber guide in which a cylindrical light diffuser is inserted...
September 25, 2017: Future Oncology
https://www.readbyqxmd.com/read/28928164/immunopet-of-malignant-and-normal-b-cells-with%C3%A2-89-zr-and%C3%A2-124-i-labeled-obinutuzumab-antibody-fragments-reveals-differential-cd20-internalization-in-vivo
#13
Kirstin A Zettlitz, Richard Tavare, Scott M Knowles, Kristopher K Steward, John M Timmerman, Anna M Wu
PURPOSE: The B-cell antigen CD20 provides a target for antibody-based positron emission tomography (immunoPET). We engineered antibody fragments targeting human CD20 and studied their potential as immunoPET tracers in transgenic mice (huCD20TM) and in a murine lymphoma model expressing human CD20. EXPERIMENTAL DESIGN: Anti-CD20 cys-diabody (cDb) and cys-minibody (cMb) based on rituximab (Rx) and obinutuzumab (GA101) were radioiodinated and used for immunoPET imaging of a murine lymphoma model...
September 19, 2017: Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
https://www.readbyqxmd.com/read/28918629/dosimetric-quantification-of-coating-related-uptake-of-silver-nanoparticles
#14
Dajana Lichtenstein, Thomas Meyer, Linda Böhmert, Sabine Juling, Christoph Fahrenson, Soeren Selve, Andreas F Thünemann, Jan Meijer, Irina Estrela-Lopis, Albert Braeuning, Alfonso Lampen
The elucidation of mechanisms underlying cellular uptake of nanoparticles is an important topic in nanotoxicological research. Most studies dealing with silver nanoparticle uptake provide only qualitative data about internalization efficiency and do not consider nanoparticle-specific dosimetry. Therefore, we performed a comprehensive comparison of the cellular uptake of differently coated silver nanoparticles of comparable size in different human intestinal Caco-2 cell-derived models to cover also the influence of the intestinal mucus barrier and uptake-specialized M-cells...
September 18, 2017: Langmuir: the ACS Journal of Surfaces and Colloids
https://www.readbyqxmd.com/read/28866268/investigating-the-state-of-physiologically-based-kinetic-modelling-practices-and-challenges-associated-with-gaining-regulatory-acceptance-of-model-applications
#15
Alicia Paini, Jeremy A Leonard, Tomas Kliment, Yu-Mei Tan, Andrew Worth
Physiologically based kinetic (PBK) models are used widely throughout a number of working sectors, including academia and industry, to provide insight into the dosimetry related to observed adverse health effects in humans and other species. Use of these models has increased over the last several decades, especially in conjunction with emerging alternative methods to animal testing, such as in vitro studies and data-driven in silico quantitative-structure-activity-relationship (QSAR) predictions. Experimental information derived from these new approach methods can be used as input for model parameters and allows for increased confidence in models for chemicals that did not have in vivo data for model calibration...
September 1, 2017: Regulatory Toxicology and Pharmacology: RTP
https://www.readbyqxmd.com/read/28864634/evaluation-of-the-lysophosphatidic-acid-receptor-type-1-radioligand-11-c-bmt-136088-for-lung-imaging-in-rhesus-monkeys
#16
Jean-Dominique Gallezot, Nabeel B Nabulsi, Daniel Holden, Shu-Fei Lin, David Labaree, Jim Ropchan, Soheila Najafzadeh, David J Donnelly, Kai Cao, Samuel Bonacorsi, Jon Seiders, Jeffrey Roppe, Wendy Hayes, Yiyun Huang, Shuyan Du, Richard E Carson
The lysophosphatidic acid receptor type 1 (LPA1) is one of six known receptors of the extracellular signaling molecule LPA. It mediates effects such as cell proliferation, migration and differentiation. In the lung, LPA1 is involved in pathways leading, after lung tissue injury, to pulmonary fibrosis instead of normal healing, by mediating fibroblast recruitment and vascular leak. Thus, a LPA1 positron emission tomography (PET) radiotracer may be useful to study lung fibrosis, or to develop LPA1-targeting drugs...
September 1, 2017: Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine
https://www.readbyqxmd.com/read/28858854/photon-iso-effective-dose-for-cancer-treatment-with-mixed-field-radiation-based-on-dose-response-assessment-from-human-and-an-animal-model-clinical-application-to-boron-neutron-capture-therapy-for-head-and-neck-cancer
#17
Sara Josefina Gonzalez, Emiliano C C Pozzi, Andrea Monti Hughes, Lucas Provenzano, Hanna Koivunoro, Daniel Germán Carando, Silvia Inés Thorp, Mariana Rosalía Casal, Silva Bortolussi, Verónica A Trivillin, Marcela A Garabalino, Paula Curotto, Elisa M Heber, Gustavo A Santa Cruz, Leena Kankaanranta, Heikki Joensuu, Amanda E Schwint
Boron Neutron Capture Therapy (BNCT) is a treatment modality that combines different radiation qualities. Since the severity of biological damage following irradiation depends on the radiation type, a quantity different from absorbed dose is required to explain effects observed in the clinical BNCT in terms of outcome compared with conventional photon radiation therapy. A new approach for calculating photon iso-effective doses in BNCT was introduced previously. The present work extends this model to include information from dose-response assessments in animal models and humans...
August 31, 2017: Physics in Medicine and Biology
https://www.readbyqxmd.com/read/28833667/dual-nuclide-radiopharmaceuticals-for-positron-emission-tomography-based-dosimetry-in-radiotherapy
#18
Alexander Wurzer, Christof Seidl, Alfred Morgenstern, Frank Bruchertseifer, Markus Schwaiger, Hans-Jürgen Wester, Johannes Notni
Improvement of the accuracy of dosimetry in radionuclide therapy has the potential to increase patient safety and therapeutic outcomes. Although positron emission tomography (PET) is ideally suited for acquisition of dosimetric data because PET is inherently quantitative and offers high sensitivity and spatial resolution, it is not directly applicable for this purpose because common therapeutic radionuclides lack the necessary positron emission. This work reports on the synthesis of dual-nuclide labeled radiopharmaceuticals with therapeutic and PET functionality, which are based on common and widely available metal radionuclides...
August 21, 2017: Chemistry: a European Journal
https://www.readbyqxmd.com/read/28830021/design-and-implementation-of-a-mobile-gamma-spectrometry-system-to-in-vivo-measure-the-accumulated-activity-of-131-i-in-patients-with-thyroid-diseases
#19
Sebastián Bahamonde, Gloria M Díaz-Londoño, Marcía García, Felipe Albornoz, Pablo Andrade
The design and implementation of a mobile gamma spectrometry system to in vivo measure the accumulated activity of (131)I in whole body and thyroid of patients with thyroid diseases are presented in this work. This system may be used for both pre-therapeutic and post-therapeutic dosimetry calculations. It consists of a detector and a movable support that allows its movement from one place to another.
November 2017: Applied Radiation and Isotopes
https://www.readbyqxmd.com/read/28821924/-89-zr-labeled-nivolumab-for-imaging-of-t-cell-infiltration-in-a-humanized-murine-model-of-lung-cancer
#20
Christopher G England, Dawei Jiang, Emily B Ehlerding, Brian T Rekoske, Paul A Ellison, Reinier Hernandez, Todd E Barnhart, Douglas G McNeel, Peng Huang, Weibo Cai
PURPOSE: Nivolumab is a human monoclonal antibody specific for programmed cell death-1 (PD-1), a negative regulator of T-cell activation and response. Acting as an immune checkpoint inhibitor, nivolumab binds to PD-1 expressed on the surface of many immune cells and prevents ligation by its natural ligands. Nivolumab is only effective in a subset of patients, and there is limited evidence supporting its use for diagnostic, monitoring, or stratification purposes. METHODS: (89)Zr-Df-nivolumab was synthesized to map the biodistribution of PD-1-expressing tumor infiltrating T-cells in vivo using a humanized murine model of lung cancer...
August 19, 2017: European Journal of Nuclear Medicine and Molecular Imaging
keyword
keyword
100206
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"